Tag: MolBio
Molbio announces collaboration with UE LifeSciences to expand iBreastExam® to the...
Collaboration to equip public and private healthcare providers to fight breast cancer with portable, pain-free, and radiation-free technology
“Truenat platform has proven itself as a breakthrough diagnostic tech for...
Sriram Natarajan, Chief Executive Officer, Molbio Diagnostics shares his insights on the company’s contribution in eradicating tuberculosis, its unique product portfolio, and future outlook
Molbio’s Truenat technology gets recognition at World Health Assembly
Molbio’s portable Truenat system praised for its impact on TB diagnosis and healthcare accessibility, expanding global reach to over 80 countries
Molbio Diagnostics partners Testi Technologies to commercialize cutting-edge saliva based self-test...
Under the current agreement, Molbio will have the rights to commercialize, market and sell PROMILLESS under its own brand name globally.
CrisprBits collaborates with Molbio Diagnostics to launch CRISPR-based Point-of-Care tests
The partnership represents a significant milestone in the advancement of accessible, cost effective and accurate diagnostic testing in the frontline